March 28 2019
Posted February 15, 2018
mGluR2/3 Blocker Drug
Building on previous work performed by the Cure Alzheimer’s Fund Stem Cell Consortium, Sam Gandy, M.D., Ph.D., at the Icahn School of Medicine at Mt. Sinai conducted studies on a drug called an “mGluR2/3 blocker”, which stimulates the creation of new nerve cells in the brain. Promising pilot results of the drug in mice helped the project secure $1 million in funding from the Veteran’s Administration for additional study.
March 28 2019
March 28 2019
March 28 2019
March 28 2019
March 28 2019
March 28 2019